Advanced General Medicine Course Specification
MD Degree in Internal Medicine
Program on which the course is given: Doctorate in Clinical and Chemical Pathology
Department offering the program: Clinical and Chemical Pathology Department
Department offering the course: Clinical and Chemical Pathology Department
Course code: CCP922CI
Element of the program (Compulsory/Elective): Elective course
Academic year: 2018-2019
Date of approval: July 2015
Date of revision: September 2018
Credit points: 10 Credit points
Course duration: 60 weeks
Teaching hours: Theoretical 53% and Practical 47%
Course Director:
- Prof. Shereen Mahmoud
Course Coordinators:
- Prof. Mariam Onsy
- Associate Prof. Safa Meshaal
I. AIM OF COURSE
The aim of the course is to develop outstanding Clinical Pathology consultants with an in-depth understanding of the principles and practices and skills in Clinical Immunology as well as the principles of good laboratory practice
II. INTENDED LEARNING OUTCOMES
A. Knowledge and Understanding:
By the end of the program the candidate should be able to:
1. Master in-depth knowledge of the development, structure and physiological function of the immune system and the pathophysiology of immunological disorders.
2. Identify the principles of laboratory diagnostic immunology.
3. Identify the pathophysiology and diagnostic criteria of immunodeficiency diseases, autoimmune diseases, and allergic diseases and select laboratory investigations used in diagnosis and follow up.
4. Demonstrate the ability to analyze lymphoid malignancy including cellular lineage, classification, and diagnosis.
5. Define HLA gene structure, expression, polymorphism, and function and identify factors relevant to transplantation immunology, pre-transplant workup, selection of recipients and donors, factors affecting outcome, and post-transplant monitoring.
6. Explain the immunology relating to transfusion of blood products, factors affecting the outcome, and investigation of complications.
7. Describe the modes of action and indications of various immunological therapies including vaccines, monoclonal antibodies, immunoglobulin and immunosuppressive drugs.
8. Outline quality assurance program for the Immunology laboratory.
B. Intellectual Skills:
By the end of the program the candidate should be able to:
1. Interpret test results in the context of the clinical presentation of the patient and produce reports with interpretive comments using quality assurance procedures.
2. Provide evidence based opinion on the clinical significance of the results of investigations including further investigations and follow up of patients.
3. Make informed decisions regarding the introduction of new immunological diagnostic test in the laboratory
4. Review scientific literature using a critical approach and effectively access relevant scientific literature.
5. Design sound research for future clinical and laboratory
C. Professional and Practical Skills:
By the end of the program the candidate should be able to:
1. Select appropriate clinical investigations and formulate the differential diagnoses in the context of the clinical presentation.
2. Perform and interpret immunological tests to assist with the diagnosis, monitoring and treatment of patients in accordance with guidelines.
3. Report results of laboratory immunological and molecular investigations with clinical interpretation.
4. Implement and adhere to guidelines and integrate them into practice.
5. Design and deliver an effective presentation.
6. Implement health and safety policies and procedures in the laboratory.
D. General and Transferable Skills:
By the end of the program the candidate should be able to:
1. Communicate effectively orally and in writing.
2. Communicate with patients in clear and simple language and with empathy.
3. Participate in interactive multidisciplinary clinical teams to advise and provide a scientific perspective.
4. Apply teamwork skills required to implement laboratory policies.
5. Expand knowledge and abilities through adopting life-long learning practices.
6. Efficiently present information at scientific meetings.